Глава 1. Фактор роста эндотелия сосудов: предпосылки и история

Литература (продолжение)

1. Suto K, Yamazaki Y, Morita T, Mizuno H. Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domaincontaining receptor but not to fms-like tyrosine kinase-1. J Biol Chem . 2005;280(3):2126-2131.
2. Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc U K . 1948;68:137-180.
3. Wise GN. Retinal neovascularization. Trans Am Ophthalmol Soc . 1956;54:729-826.
4. Miller JW. The Harvard angiogenesis story. Surv Ophthalmol . 2014;59(3):361-364.
5. Glaser BM, D’Amore PA, Lutty GA, Fenselau AH, Michels RG, Patz A. Chemical mediators of intraocular neovascularization. Trans Ophthalmol Soc U K . 1980;100(3):369-373.
6. Glaser BM, D’Amore PA, Michels RG, et al. The demonstration of angiogenic activity from ocular tissues. Preliminary report. Ophthalmology. 1980;87(5):440-446.
7. Glaser BM, D’Amore PA, Michels RG, Patz A, Fenselau A. Demonstration of vasoproliferative activity from mammalian retina. J Cell Biol . 1980;84(2):298-304.
8. D’Amore PA, Glaser BM, Brunson SK, Fenselau AH. Angiogenic activity from bovine retina: partial purification and characterization. Proc Natl Acad Sci U S A . 1981;78(5):3068-3072.
9. Sivalingam A, Kenney J, Brown GC, Benson WE, Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol. 1990;108(6):869-872.
10. Plate KH, Breier G, Welch HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992;359(6398):845-848.
11. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359(6398):843-845.
12. Kim LA, D’Amore PA. A brief history of anti-VEGF for the treatment of ocular angiogenesis. Am J Pathol . 2012;181(2):376-379.
13. Adamis AP, Shima DT, Yeo KT, et al. Synthesis and secretion of vascular permeability factor/ vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun . 1993;193(2):631-638.
14. Shima DT, Deutsch U, D’Amore, PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett. 1995;370(3):203-208.
15. Shima DT, Adamis AP, Ferrara N, et al. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med . 1995;1(2):182-193.
16. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994;145(3):574-584.
17. Shima DT, Gougos A, Miller JW, et al. Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. Invest Ophthalmol Vis Sci. 1996;37(7):1334-1340.
18. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med . 1994;31(22):1480-1487.
19. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol . 1994;118(4):445-450.
20. Tolentino MJ, Miller JW, Gragoudas ES, Chatzistefanou K, Ferrara N, Adamis AP. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol . 1996;114(8):964-970.
21. Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology. 1996;103(11):1820-1828.
22. Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A . 1995;92(23):10457-10461.